Stellar Biotechnologies Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$3 |
Market Cap |
$7.46 M |
Shares Outstanding |
5.33 M |
Public Float |
4.53 M |
Address |
332 East Scott Street Port Hueneme California 93041 United States |
Employees | - |
Website | http://www.stellarbiotechnologies.com |
Updated | 09/14/2018 |
Stellar Biotechnologies, Inc. engages in the research, development, manufacture, and commercialization of Keyhole Limpet Hemocyanin (KLH), an immune-stimulating protein utilized as a carrier molecule in therapeutic vaccines and for assessing immune system function. Its product portfolio includes Stellar KLH Products, Stellar KLH Protein, and Stellar KLH ELISA Kits. The Company was founded on June 12, 2007 and is headquartered in Port Hueneme, CA. |